Data Characteristics in This Category
Metabolic and endocrine clinical trial data originates from global clinical trial registries (e.g., ClinicalTrials.gov, EU Clinical Trials Register), medical journal databases (e.g., PubMed, Embase), review reports from drug regulatory agencies (e.g., FDA, EMA), and pharmaceutical company disclosures. Update frequencies vary. Registries may update daily; journal articles and review reports have fixed publication cycles. Document formats are diverse. These include structured trial protocols, research report PDFs, unstructured news releases, and conference abstracts. Key fields include disease names (e.g., "Type 2 Diabetes," "Hypothyroidism"), drug names, primary/secondary endpoints (e.g., HbA1c reduction percentage, weight change), subject inclusion/exclusion criteria, trial phase, number of centers, and trial status. Units often involve blood glucose concentration (mmol/L or mg/dL), hormone levels (pmol/L, ng/dL), weight (kg), and blood pressure (mmHg). Multiple measurement units coexist.
Constraints from "Citation and Traceability"
The diversity and complexity of metabolic and endocrine clinical trial data impose specific requirements on citation and traceability. First, broad and varied data sources necessitate standardized processing of documents during knowledge base construction. This ensures accurate linking to original sources during retrieval. Second, the field involves extensive specialized terminology and units. For example, different diabetes drugs have distinct mechanisms and evaluation metrics. Knowledge base chunking and vectorization must preserve the semantic integrity of this domain knowledge. This avoids citation distortion from overly coarse or fine granularity. Third, the timeliness of clinical trial data, especially new drug trial results, requires rapid knowledge base updates to reflect the latest information. Citing outdated or retracted literature can lead to erroneous pre-screening results. Therefore, citation traceability must point to the original document and indicate its publication date or update status. This allows assessment of information timeliness.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500–800 characters | Ensures critical clinical trial information, such as primary endpoints and subject characteristics, is fully expressed within a single chunk. This reduces semantic fragmentation. |
Recall count (Recall Count) | Top 5–8 items | Metabolic and endocrine trials are complex and similar. Increasing the recall count helps cover more potentially relevant literature, improving pre-screening accuracy. |
Similarity threshold (Similarity Threshold) | Set by empirical measurement | Determine this through cross-validation based on the actual dataset characteristics. This balances recall and precision, preventing citation of low-relevance documents. |
Rerank result count (Reranked Return Count) | Top 3 items | After reranking, prioritize displaying the few most relevant documents to the user's query. This improves information retrieval efficiency. |
maxContext | 4000–6000 tokens | Accommodates more contextual information. This supports the model's in-depth understanding and reasoning of complex clinical trial protocols and results. |
PARSE_FILE_TIMEOUT_SECONDS | 300 seconds | Processing large PDF clinical trial reports can take significant time. This prevents parsing timeouts and data loss. |
Three Common Mistakes
- Retrieval results show citations irrelevant to the query, but the content appears related. This happens when knowledge base chunking granularity is inappropriate. A chunk might contain fragmented information from multiple documents, or semantically similar but contextually different text is incorrectly associated.
- The dialogue request interface does not return
citecitation IDs or the citation content is empty. This can occur if citation return functionality is not enabled in the knowledge base configuration, or if retrieved chunks fail to pass confidence threshold filtering. - Citation sources point to outdated or retracted clinical trial results. This indicates an imperfect knowledge base update mechanism. It fails to synchronize the latest clinical trial data and literature status in a timely manner.
How to Confirm Correct Configuration
- For typical queries, check if returned citations point to original clinical trial reports or journal articles. Verify consistency between key data (e.g., drug dosage, primary endpoint values) in the report and the model-generated content.
- Simulate various query scenarios, especially complex queries involving multiple diseases or drug combinations. Check if
citecitation IDs are consistently returned and if each ID corresponds to a traceable knowledge source. - Periodically sample and check the publication date or update status of cited documents. Ensure all citations use the latest and valid clinical trial data. For updated or retracted documents, verify the knowledge base has synchronized and adjusted citations accordingly.
Note: The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.